| Dr Elizabeth A Sawyer Scovel, PHD | |
|
2400 Main St, Vancouver, WA 98660-2663 | |
| (360) 574-9565 | |
| (360) 574-9685 |
| Full Name | Dr Elizabeth A Sawyer Scovel |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 29 Years |
| Location | 2400 Main St, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093817991 | NPI | - | NPPES |
| 8387185 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY2986 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geromedical Psychological Service Ps | 9436180684 | 2 |
News Archive
Several studies have shown that those with Vitamin D deficiency also have symptoms of depressive illness. The authors wrote, "Low levels of 25-hydroxyvitamin D have been associated with a higher risk for depression later in life, but there have been few long-term, high-dose large-scale trials."
Chemists and biologists at Virginia Tech continuing to design light-activated molecular systems to attack cancer cells have introduced a DNA targeting component.
Adolescence is both a time of rapid neurobiological changes and of the initiation of drinking - alcohol is the most commonly used substance among students in grades eight to 12.
ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.
› Verified 5 days ago
| Entity Name | Geromedical Psychological Service Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659482925 PECOS PAC ID: 9436180684 Enrollment ID: O20050826000611 |
News Archive
Several studies have shown that those with Vitamin D deficiency also have symptoms of depressive illness. The authors wrote, "Low levels of 25-hydroxyvitamin D have been associated with a higher risk for depression later in life, but there have been few long-term, high-dose large-scale trials."
Chemists and biologists at Virginia Tech continuing to design light-activated molecular systems to attack cancer cells have introduced a DNA targeting component.
Adolescence is both a time of rapid neurobiological changes and of the initiation of drinking - alcohol is the most commonly used substance among students in grades eight to 12.
ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth A Sawyer Scovel, PHD 2400 Main St, Vancouver, WA 98660-2663 Ph: (360) 574-9565 | Dr Elizabeth A Sawyer Scovel, PHD 2400 Main St, Vancouver, WA 98660-2663 Ph: (360) 574-9565 |
News Archive
Several studies have shown that those with Vitamin D deficiency also have symptoms of depressive illness. The authors wrote, "Low levels of 25-hydroxyvitamin D have been associated with a higher risk for depression later in life, but there have been few long-term, high-dose large-scale trials."
Chemists and biologists at Virginia Tech continuing to design light-activated molecular systems to attack cancer cells have introduced a DNA targeting component.
Adolescence is both a time of rapid neurobiological changes and of the initiation of drinking - alcohol is the most commonly used substance among students in grades eight to 12.
ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.
› Verified 5 days ago
Dr. Bart James Fowler, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11802 Ne 117th Ave, Vancouver, WA 98662 Phone: 360-891-2000 Fax: 360-944-6965 | |
Margaret Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 955 Officers Row, Vancouver, WA 98661 Phone: 360-213-7893 | |
Dr. Lucretia Hyzy Krebs, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1701 E Evergreen Blvd, Vancouver, WA 98661 Phone: 360-513-5572 Fax: 360-263-2681 | |
Shelly Nicol, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7507 Ne 51st St, Vancouver, WA 98662 Phone: 360-906-1190 | |
Dr. Maria Lise Flores, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 400 E Evergreen Blvd Ste 102, Vancouver, WA 98660 Phone: 564-232-8225 | |
Mrs. Anneliese J Corcoran, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 9340 Ne 76th St, Vancouver, Vancouver, WA 98662 Phone: 360-253-4912 Fax: 360-253-4912 | |
Dr. Cynthia Ann Savoie, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8120 Ne Royal St, Vancouver, WA 98662 Phone: 360-256-9465 Fax: 360-256-2378 |